Personalized Medicine Market by Segments, Sub-market, Therapy and Geography Analysis and Forecasts to 2019
RnRMarketResearch.com provides Personalized Medicine, Targeted Therapeutics & Companion Diagnostic Market to 2019 report in its store. The report highlights a number of significant pharmacos and gives details of their operations, products, financials and business strategy.
October 16, 2015 /MarketersMedia/ —
“Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market – A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment to 2019” report provides a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments.
The Complete Report Personalized Medicine, Targeted Therapeutics & Companion Diagnostic Market by Segment (Targeted therapeutics, Companion Diagnostics), By Sub-market (Companion diagnostic, targeted cancer therapeutic, medical technology, pharmacogenomics, consumer, genomics, molecular diagnostics), By Therapy (Cancer, Cardiovascular, Infectious Disease), By Geography (US, UK, Global) and By Company (e.g., QIAGEN, AFFYMETRIX, ATOSSA GENETICS, NODALITY, CELERA, MYRIAD) spreads across 279 page and is supported by over 317 tables & figures is available at http://www.rnrmarketresearch.com/personalized-medicine-targeted-therapeutics-companion-diagnostic-market-to-2019-market-report.html.
A wealth of financial data & business strategy information is provided including:
• Company financials, sales & revenue figures
• Business Model Strategies for Diagnostic, Pharmaceutical and Biotechnology Companies
• Business Model Strategies for Providers. Provider Systems and Academic Medical Centres
• Business Model Strategies for Payers & Governments
• Private and Public Funding and Personalized Medicine Reimbursement
• Revisions to Current Payment Systems and intellectual property
• How to Gain Market Penetration in the EU
• Cost-effectiveness and Business Value of Personalized Medicine
• Consumer genomics, molecular diagnostics and POC market
• Therapeutics and Companion Diagnostics (e.g., BRAC Analysis, Oncotype Dx , KRAS Mutations)
• Comprehensive account of company product portfolios & kits
SWOT, Economic & Regulatory Environment specifics include:
• Key strengths, weaknesses and threats influencing leading player position within the market
• Technologies driving the market (e.g., New-Generation Sequencing Technologies, Ultra-High Throughput Sequencing)
• Top fastest growing market segments and emerging opportunities
• Top pharmaceutical companies within the IPM by market share and revenue
• Comprehensive product portfolios, R&D activity and pipeline therapeutics
• M&A activity and future strategies of top personalized medicine pharmacos
• Personalized Medicine Regulation (UK, Germany, France, Spain, Italy)
• CE-marked Personalized Medicine/Diagnostic Tests
• FDA Advances in Personalized Medicine Regulation
Order a Single User License Copy of Personalized Medicine, Targeted Therapeutics & Companion Diagnostic Market to 2019 Report at http://www.rnrmarketresearch.com/contacts/purchase?rname=393156 for US $3400.
This report highlights a number of significant pharmacos and gives details of their operations, products, financials and business strategy.
List of Companies: 23andMe, Affymetrix, Astex Pharmaceuticals, Atossa Genetics, CuraGen, Celera Corporation (Quest Diagnostics), Celldex Therapeutics, deCode Genetics (Amgen), Illumina, Genelex, Myriad, Nodality, Qiagen, Admera Health (GeneWiz) and Claritas Genomics.
Report Highlights:
• An in-depth understanding of the global personalized medicine market and it’s environment
• Current market facts, figures and product lines of key players in the industry
• Emerging trends in key markets such as the US, UK, Germany and France
• Knowledge of how the personalized medicine market will integrate into the global healthcare market
• Technical insights into new generation sequencing technologies and ultra-high throughput sequencing
• Updates on bioinformatics, high throughput systems, genetic analysis kits, companion diagnostics and future technologies
• FDA approved pharmacogenetic tests and recognized biomarkers
• Information on key government and regulatory policies
• Strategies on how to adapt and restructure current business models to this industry
This report tackles key concerns to the personalized medicine market such as:
• Lack of regulatory policy and legislation in the US and Europe
• Reimbursement schemes and payers concerns
• Transition of investigational diagnostic assays and therapeutics to clinical practice
• Direct to consumer (DTC) test kits and implications for the public
Report Useful for:
• Pharmaceutical, biotechnology and diagnostic companies with an interest in personalized medicine
• Industry professionals and business strategists will discover key information to propel their policies
• Investors will gain inside information to dominant players in the industry and future forecasts
• Scientists will get a business perspective and industry insight into how scientific breakthroughs influence the market environment
This report will tell if the companies mentioned are:
• Strong, competitive players
• Pooling their resources for specific growth and therapeutic areas
• Investing strategically in R&D
• Have a history of strategic M&A activity
Major Points from Table of Content:
1.0 Executive Summary
2.0 Introduction and Background
3.0 Personalized Medicine Therapeutics and Associated Companion Diagnostics
4.0 Personalized Medicine and Integration into the Healthcare System
5.0 Private and Public Funding and Personalized Medicine Reimbursement
6.0 European Personalized Medicine Market – Payments and Investment
7.0 Personalized Medicine –Business Model Analysis
8.0 Personalized Medicine Main Industry Players
9.0 Personalized Medicine Industry Products and Kits
10.0 Personalized Medicine Market Analysis
11.0 Strengths and Advantages of Personalized Medicine
12.0 Restraints of the Personalized Medicine Market
13.0 Personalized Medicine and Regulatory Policies
14.0 Final Summary and Future Perspectives
List of Tables
Explore other report by Kelly Scientific Publications http://www.rnrmarketresearch.com/publisher/Kelly-Scientific-Publications.html.
About
RnRMarketResearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
For more information about us, please visit http://www.rnrmarketresearch.com/personalized-medicine-targeted-therapeutics-companion-diagnostic-market-to-2019-market-report.html
Contact Info:
Name: Ritesh Tiwari
Organization: RnRMarketResearch
Phone: + 1 888 391 5441
Release ID: 94090
Copyright © 1999-2013 SproutNews.com
